Patients with loss of function signal transducer and activator of transcription 3-related Hyper IgE Syndrome (LOF STAT3 HIES) present with recurrent staphylococcal skin and pulmonary infections along with the elevated serum IgE levels, eczematous rashes, and skeletal and facial abnormalities. Defective STAT3 signaling results in reduced Th17 cells and an impaired IL-17/IL-22 response primarily due to a compromised canonical Janus kinase-signal transducer and activator of transcription (JAK–STAT) pathway that involves STAT3 phosphorylation, dimerization, nuclear translocation, and gene transcription. The non-canonical pathway involving unphosphorylated STAT3 and its role in disease pathogenesis, however, is unexplored in HIES.
This study aims to elucidate the role of unphosphorylated STAT3–unphosphorylated NF-κB (uSTAT3–uNF-κB) activation pathway in LOF STAT3 HIES patients.
The mRNA expression of downstream molecules of unphosphorylated STAT3–unphosphorylated NF-κB pathway was studied in five LOF STAT3 HIES patients and transfected STAT3 mutants post-IL-6 stimulation. Immunoprecipitation assays were performed to assess the binding of STAT3 and NF-κB to RANTES promoter.
A reduced expression of the downstream signaling molecules of the uSTAT3–uNF-κB complex pathway, viz.,
The reduced expression of downstream signaling molecules, specially